Basic info
Industry
biotechnology research
Sectors
Biotechnology
Health Care
Therapeutics
Medical
Diabetes
Regenerative Medicine
Cell Therapy
Date founded
1999
Funding rounds raised
Total raised
$80M
from 10 investors over 10 rounds
V
ViaCyte (formerly Novocell) raised undisclosed on April 22, 2021
Investors: Asymmetry Ventures
V
ViaCyte (formerly Novocell) raised $33M on March 20, 2020
Investors: Sanderling Ventures and RA Capital Management, L.P.
V
ViaCyte (formerly Novocell) raised $80M on November 29, 2018
Investors: Sanderling Ventures, TPG Global and RA Capital Management, L.P.
V
ViaCyte (formerly Novocell) raised $10M on September 25, 2018
Investors: W. L. Gore & Associates
V
ViaCyte (formerly Novocell) raised undisclosed on April 17, 2018
Investors: NIDDK, NIH
V
ViaCyte (formerly Novocell) raised $10M on May 22, 2017
Investors: Valterna AG and W. L. Gore & Associates